HomeINTI • OTCMKTS
add
Inhibitor Therapeutics Inc
Previous close
$0.045
Year range
$0.034 - $0.078
Market cap
7.77M USD
Avg Volume
10.90K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 741.22K | -8.85% |
Net income | -712.18K | 2.57% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.98M | -53.33% |
Total assets | 3.14M | -51.40% |
Total liabilities | 3.13M | 2.86% |
Total equity | 3.45K | — |
Shares outstanding | 172.57M | — |
Price to book | ∞ | — |
Return on assets | -52.62% | — |
Return on capital | -426.59% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -712.18K | 2.57% |
Cash from operations | -761.24K | -5.66% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -761.24K | -5.66% |
Free cash flow | -512.56K | -2.98% |
About
Founded
1992
Headquarters
Website
Employees
6
